Novel screening method for multiple myeloma prognosis gene
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- THE FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIV
- Publication Date
- 2019-09-10
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for screening multiple myeloma prognosis genes based on a gene co-expression network. Background technique
[0002] Multiple myeloma (MM) is a malignant plasma cell disease in which tumor cells originate from plasma cells in the bone marrow, which are cells that develop to the final functional stage of B lymphocytes. At present, the heterogeneity of multiple myeloma has been paid more and more attention. However, there is no screening method for multiple myeloma prognostic genes in the world. Contents of the invention
[0003] The present invention provides a screening method for multiple myeloma prognosis genes based on gene co-expression network, which can effectively solve the above problems.
[0004] The present invention is achieved like this:
[0005] A method for screening multiple myeloma prognosis genes based on a gene co-expression network, characterized in that it comprises the following steps:
[0006] ...